What is Ozempic?
An introduction to Ozempic, the brand name for semaglutide approved for type 2 diabetes.
Last updated: January 28, 2026
What is Ozempic?
Ozempic is a brand name for semaglutide, a medication approved by the FDA for treating type 2 diabetes. It’s manufactured by Novo Nordisk and was approved in December 2017.
How is Ozempic Different from Wegovy?
Both Ozempic and Wegovy contain the same active ingredient (semaglutide), but they’re approved for different purposes:
| Brand | Ozempic | Wegovy |
|---|---|---|
| Approved For | Type 2 diabetes | Weight management |
| Max Dose | 2 mg weekly | 2.4 mg weekly |
| FDA Approval | 2017 | 2021 |
How Does Ozempic Work?
Ozempic mimics a natural hormone called GLP-1 (glucagon-like peptide-1). When you inject Ozempic weekly, it:
- Stimulates insulin release when blood sugar is elevated
- Reduces glucagon secretion to prevent excess glucose production
- Slows gastric emptying to reduce post-meal blood sugar spikes
- Acts on the brain to reduce appetite
What is Ozempic Approved For?
FDA-Approved Indications
- Type 2 diabetes — to improve blood sugar control alongside diet and exercise
- Cardiovascular risk reduction — to reduce risk of major cardiovascular events in adults with type 2 diabetes and established heart disease
Not Approved For
- Weight loss (use Wegovy instead)
- Type 1 diabetes
- Diabetic ketoacidosis
Key Facts
| Fact | Detail |
|---|---|
| Active Ingredient | Semaglutide |
| Administration | Once weekly injection |
| Available Doses | 0.25 mg, 0.5 mg, 1 mg, 2 mg |
| Manufacturer | Novo Nordisk |
Common Side Effects
- Nausea (usually improves with time)
- Diarrhea or constipation
- Abdominal pain
- Decreased appetite
Who Should Not Use Ozempic?
- People with personal or family history of medullary thyroid carcinoma
- People with Multiple Endocrine Neoplasia syndrome type 2
- Those with known hypersensitivity to semaglutide
This guide is for educational purposes only. Ozempic is a prescription medication that requires medical supervision.
Related Content
5-Amino-1MQ
Metabolic · low evidence
Amycretin
Metabolic · moderate evidence
AOD-9604
Metabolic · low evidence
What is Ozempic?
An introduction to Ozempic, the brand name for semaglutide a...
What is Rybelsus?
An introduction to Rybelsus, the oral tablet form of semaglu...
5-Amino-1MQ vs Semaglutide
View side-by-side analysis
Amycretin vs Semaglutide
View side-by-side analysis
Get Research Alerts
New dossiers and major study summaries delivered to your inbox. No spam, just evidence.
No spam. Unsubscribe anytime.
Disclaimer: This educational guide does not constitute medical advice. The information presented is based on current research but should not be used for diagnosis, treatment, or prevention of any disease. Always consult a qualified healthcare provider before making health decisions.